Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             27 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan Rocha-Lima, Caio Max
2014
74 3 p. 479-486
artikel
2 A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer Ikeda, Takaya
2014
74 3 p. 497-502
artikel
3 A phase 1 study to evaluate effect of food on veliparib pharmacokinetics and relative bioavailability in subjects with solid tumors Mostafa, Nael M.
2014
74 3 p. 583-591
artikel
4 Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level Gong, Anjing
2014
74 3 p. 531-538
artikel
5 Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study Zheng, Yulong
2014
74 3 p. 503-509
artikel
6 Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients Koh, Youngil
2014
74 3 p. 653-657
artikel
7 Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer Vijayvergia, Namrata
2014
74 3 p. 437-446
artikel
8 Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer Choi, Moon Ki
2014
74 3 p. 521-529
artikel
9 Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx®) Boers-Sonderen, Marye J.
2014
74 3 p. 457-463
artikel
10 Determining the mechanisms of lapatinib-induced diarrhoea using a rat model Bowen, Joanne M.
2014
74 3 p. 617-627
artikel
11 Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers Chen, Nianhang
2014
74 3 p. 659-660
artikel
12 Inhibition of Hec1 as a novel approach for treatment of primary liver cancer Huang, Lynn YL
2014
74 3 p. 511-520
artikel
13 KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma Zheng, Yun
2014
74 3 p. 487-495
artikel
14 Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi’s sarcoma (KS) Bendle, M.
2014
74 3 p. 611-615
artikel
15 Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia Kaefer, Aksana
2014
74 3 p. 593-602
artikel
16 Metronomics chemotherapy: time for computational decision support Barbolosi, Dominique
2014
74 3 p. 647-652
artikel
17 Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice Hassan, Memy H.
2014
74 3 p. 559-569
artikel
18 No pharmacokinetic alteration of docetaxel following coadministration of aprepitant 3 h before docetaxel infusion Kaneta, Toshikado
2014
74 3 p. 539-547
artikel
19 Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors Galsky, Matthew D.
2014
74 3 p. 465-471
artikel
20 Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy Yang, Jianliang
2014
74 3 p. 637-646
artikel
21 Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors Doi, Toshihiko
2014
74 3 p. 629-636
artikel
22 Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer Lee, Keun-Wook
2014
74 3 p. 447-455
artikel
23 Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia Chalret du Rieu, Quentin
2014
74 3 p. 571-582
artikel
24 RETRACTED ARTICLE: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level Gong, Anjing

74 3 p. 531-538
artikel
25 Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy Wen, Chengtao
2014
74 3 p. 473-478
artikel
26 Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404 Shien, Tadahiko
2014
74 3 p. 603-609
artikel
27 Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide Stedingk, Hans von
2014
74 3 p. 549-558
artikel
                             27 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland